ATHE · Alterity Therapeutics Ltd
$4.44
-0.13 (-2.74%)
At close · Jul 29
Market Cap
$80.48M
Shares
18.13M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-15 | Gozlan Lawrence Bernard |
Director |
Award↑
|
Listed option exp 15 Jun 2031
(I)
|
1,000,000 |
| 2026-06-15 | Babarczy Julian Michael |
Director |
Award↑
|
Unlisted option exp 15 Jun 2031
(I)
|
2,000,000 |
| 2026-04-17 | Cunningham Ann Michelle |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-10 | Babarczy Julian Michael |
Director |
Other↑
|
No Securities Owned
|
0 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–4 of 4 transactions